Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction

American Journal of Cardiology

Volumn 93, Issue 7, 2004, Pages 822-825

  Merlini, Piera Angelica ^a   Cugno, Massimo ^b   Rossi, Marco L ^b   Agricola, Pietro ^b   Repetto, Alessandra ^b   Fetiveau, Raffaella ^b   Diotallevi, Paolo ^b   Canosi, Umberto ^b   Mannucci, Pier Mannuccio ^b   Ardissino, Diego ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BLOOD CLOTTING FACTOR 12; C REACTIVE PROTEIN; FIBRINOLYTIC AGENT; HEPARIN; INTERLEUKIN 6; KININOGEN; PROTHROMBIN;

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD SAMPLING; BOLUS INJECTION; CLINICAL ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HUMAN; INFLAMMATION; PATIENT MONITORING; PRIORITY JOURNAL;

C-REACTIVE PROTEIN; FACTOR XIIA; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INTERLEUKIN-6; KININOGEN, HIGH-MOLECULAR-WEIGHT; MYOCARDIAL INFARCTION; MYOCARDITIS; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; PROTHROMBIN; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 12144286171     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.12.017     Document Type: Article

References (22)

1. Eisenberg P.R., Sherman L.A., Jaffe A.D. Paradoxic elevation of fibrinopeptide A after streptokinase evidence for continued thrombosis despite fibrinolysis. J Am Coll Cardiol. 10:1987;527-529.
2. Owen J., Friedman K.D., Grossman B.A., Wilkins C., Berke A.D., Powers E.R. Fibrinolytic therapy with tissue-type plasminogen activator or streptokinase induce transient thrombin activity. Blood. 72:1988;616-620.
3. Eisenberg P.R., Sobel B.E., Jaffe A.S. Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol. 19:1992;1065-1069.
4. Rapold H.J., de Bono D., Arnold A.E., Amount J., De Cock F., Collen D., Verstraete M. Plasma fibrinopeptide A levels in patients with myocardial infarction treated with alteplase. Circulation. 85:1992;928-934.
5. Gurbel P., Serebruany V., Shustov A.T., Bahr R.D., Carpo C., Ohman E.M., Topol E.J. Effect of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. J Am Coll Cardiol. 31:1998;1466-1473.
6. Garabedian H.D., Gold H.K. Coronary thrombolysis, conjunctive heparin infusion and the effect on systemic thrombin activity. Circulation. 85:1992;1205-1207.
7. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Spinola A, Cattaneo M, Marco M, Mannucci PM, Rosenberg RD. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1995;25:203-208
8. Ewald G.A., Eisenberg P.R. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation. 91:1995;28-36.
9. Ghebrehiwet B., Randazzo B.P., Dunn J.T., Silverberg M., Kaplan A.P. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest. 71:1983;1450-1456.
10. Toss Z., Sedor J.R., Mettler M.A., Everson B., Young T., Ratnoff O.D. Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII). Proc Natl Acad Sci USA. 89:1992;11969-11972.
11. Wachtfogel Y.T., Pixley R.A., Kucick U., Abrams W., Weinbaum G., Shapira M., Colman R.W. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood. 67:1986;1731-1737.
12. Scott C.F., Shull B., Müller-Esterl W., Colman R.W. Rapid direct determination of low and high molecular weight kininogen in human plasma by particle concentration fluorescence immunoassay (PCFIA). Thromb Haemost. 77:1997;109-118.
13. Berrettini M., Lämmle B., White T., Heeb M.J., Schwartz H.P., Zuraw B., Curd J., Griffin J.H. Detection of the in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood. 68:1986;455-462.
14. Cugno M., Cicardi M., Agostoni A. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol. 93:1994;870-876.
15. Esnouf M.P., Burgess A.I., Dodds A.W., Sarphie A.F., Miller G.J. A monoclonal antibody raised against human b-factor XIIa which also recognizes a-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor. Thromb Haemost. 83:2000;874-981.
16. Agostoni A., Gardinali M., Frangi D., Cafaro C., Conciato L., Sponzilli C., Salvioni A., Cugno M., Cicardi M. Activation of complement and kinin system after thrombolytic therapy in patients with acute myocardial infarction. Circulation. 90:1994;2666-2670.
17. Hoffmeister H.M., Szabo S., Kastner C., Beyer M.E., Helber U., Kazmaier S., Wendel H.P., Heller W., Seipel L. Thrombolytic therapy in acute myocardial infarction comparison of procoagulant effect of streptokinase and alteplase regimen with focus on the kallikrein system, and plasmin. Circulation. 98:1998;2527-2533.
18. Hoffmeister H.M., Szabo S., Helber U., Seipel L. The thrombolytic paradox. Thromb Res. 103:2001;S51-S55.
19. Pixley R.A., Cassello A., De La Cadena R., Kaufman N., Colman R.W. Effect of heparin on the activation of factor XII and the contact system in plasma. Thromb Haemost. 66:1991;540-547.
20. Sturk A., Hack C.E., Aarden L.A., Brouer M., Koster R.R., Sanders G.T. Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction a pilot study. J Lab Clin Med. 119:1992;574-579.
21. Ikeda U., Ikeda M., Seino Y., Takahashi M., Kasahara T., Kano S., Shimada K. Expression of intracellular adhesion molecule 1 in rat vascular smooth muscle cells by proinflammatory cytokines. Atherosclerosis. 104:1993;61-68.
22. Montavi A. The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment. Drugs. 97:1997;15-23.